C9ORF64 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.089400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.319000E-01
Normal-vs-Stage2
7.854600E-01
Normal-vs-Stage3
3.829600E-02
Normal-vs-Stage4
8.819200E-01
Stage1-vs-Stage2
6.239600E-01
Stage1-vs-Stage3
6.261000E-03
Stage1-vs-Stage4
8.818400E-01
Stage2-vs-Stage3
3.005600E-02
Stage2-vs-Stage4
5.594000E-01
Stage3-vs-Stage4
1.395390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.875800E-01
Normal-vs-AfricanAmerican
8.611600E-01
Normal-vs-Asian
5.041800E-01
Caucasian-vs-AfricanAmerican
4.737800E-01
Caucasian-vs-Asian
2.513400E-01
AfricanAmerican-vs-Asian
2.984000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.468000E-01
Normal-vs-Female
8.742800E-01
Male-vs-Female
5.514000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.178000E-01
Normal-vs-Age(41-60Yrs)
8.287000E-01
Normal-vs-Age(61-80Yrs)
6.166600E-01
Normal-vs-Age(81-100Yrs)
8.331600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.328000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.564600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.557400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.205510E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.759000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.028600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.472800E-01
Normal-vs-Daily Drinker
3.527200E-01
Normal-vs-Weekly Drinker
8.396200E-01
Normal-vs-Occasional Drinker
9.542600E-01
Normal-vs-Social Drinker
7.911200E-01
Non Drinker-vs-Daily Drinker
7.850600E-01
Non Drinker-vs-Weekly Drinker
3.463000E-01
Non Drinker-vs-Occasional Drinker
2.027000E-01
Non Drinker-vs-Social Drinker
5.415800E-02
Daily Drinker-vs-Weekly Drinker
2.548400E-01
Daily Drinker-vs-Occasional Drinker
1.505400E-01
Daily Drinker-vs-Social Drinker
3.486000E-02
Weekly Drinker-vs-Occasional Drinker
8.134200E-01
Weekly Drinker-vs-Social Drinker
4.363000E-01
Occasional Drinker-vs-Social Drinker
5.921600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.252400E-01
Normal-vs-Grade 2
1.212370E-01
Normal-vs-Grade 3
8.359800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.395000E-01
Grade 1-vs-Grade 3
4.652000E-01
Grade 1-vs-Grade 4
2.252400E-01
Grade 2-vs-Grade 3
8.455600E-01
Grade 2-vs-Grade 4
1.212370E-01
Grade 3-vs-Grade 4
8.359800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.924200E-01
Normal-vs-NonDiabetic
8.041600E-01
Diabetic-vs-NonDiabetic
7.954100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.040600E-01
Normal-vs-NoPancreatitis
7.744200E-01
Pancreatitis-vs-NoPancreatitis
1.113050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.065600E-01
Normal-vs-N1
8.423600E-01
N0-vs-N1
7.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.482800E-01
Normal-vs-TP53-NonMutant
8.825000E-01
TP53-Mutant-vs-TP53-NonMutant
9.393200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
